glp-1 news nov 2025 Retailers across the country are noticing a spike in returns of clothing as more Americans embrace drugs for weight loss. The rate of retail exchanges where shoppers traded clothing for a GLP-1 Trends: Costs & Coverage

Anti-inflammatory effects of glucagon-like peptide-1 (GLP-1) in coronary artery disease: a comprehensive review

The peptide research community benefits collectively when researchers share their evaluation findings, helping others identify quality sources more efficiently

2025: Novo Nordisk announced positive Phase 3 ESSENCE trial results for semaglutide in early Alzheimer's disease, reporting statistically significant slowing of cognitive and functional decline a breakthrough data package that could establish GLP-1 therapy as a neuroprotective agent and open an addressable market of 6.5 million Alzheimer's patients in the U.S

Similar content being viewed by others Introduction Several physiological functions, including those of the endocrine and metabolic systems, depend on G-protein-coupled receptor (GPCR) signaling 1,2,3,4,5,6

US Judge Denies Injunction, Restricting Copies of Lilly Weight-Loss Drug. Reuters

Thats why some people are surprised by how they feel once the scales start moving